We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 602.00
Bid: 601.40
Ask: 602.00
Change: 85.00 (16.44%)
Spread: 0.60 (0.10%)
Open: 515.60
High: 624.00
Low: 512.40
Prev. Close: 517.00
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Stabilisation Notice

30 Apr 2021 07:29

RNS Number : 2017X
Jefferies International Limited.
30 April 2021
 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL

 

Darktrace plc

 

Pre-Stabilisation Period Notice

 

30 April 2021

 

Jefferies International Limited (contact: Luca Erpici; telephone: +44 20 7029 8415, Oliver Berwin; telephone: +44 20 7029 8964) hereby gives notice that it, and its affiliates, may stabilise the offer of the following securities in accordance with the relevant provisions of Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052, in each case as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

 

The securities:

 

Issuer:

 

Darktrace plc

Securities to be stabilised:

 

 

Places where stabilisation may be undertaken:

 

Security identifier:

 

Ordinary shares of 1 pence each in the capital of Darktrace plc (ISIN: GB00BNYK8G86) (the "Shares")

 

London Stock Exchange, Over-The-Counter (OTC) and other order book venues e.g. Turquoise, BATS and Chi-X

 

DARK

Offering size:

 

66,036,904 Ordinary Shares (excluding the over-allotment option)

Offer price:

 

250 pence per Share (the "Offer Price")

Stabilisation:

 

Stabilising Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

 

Jefferies International Limited, 100 Bishopsgate, London, EC2N 4JL

 

Contact: Luca Erpici; telephone: +44 20 7029 8415

Oliver Berwin; telephone: +44 20 7029 8964

 

Stabilisation period expected to start on:

 

8:00am on 30 April 2021

Stabilisation period expected to end no later than:

 

30 May 2021

Maximum size of over-allotment facility:

 

9,905,535 new Shares

Over-allotment Option:

 

Terms:

In connection with the offering (the "Global Offer"), Jefferies International Limited, as Stabilising Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Shares sold in the Global Offer or effect other stabilisation transactions with a view to supporting the market price of the Shares at a higher level than that which might otherwise prevail in the open market (the "Overallotment Option").

 

The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings of the Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. However, there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Shares above the Offer Price. Except as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Global Offer.

 

In connection with the Global Offer, the Stabilising Manager may, for stabilisation purposes, over-allot Shares up to a maximum of 15% of the total number of Shares comprised in the Global Offer. For the purposes of allowing the Stabilising Manager to cover short positions resulting from any such over-allotments and/or from sales of Shares effected by it during the stabilising period, the Company has granted the Stabilising Manager the Over-allotment Option, pursuant to which the Stabilising Manager may subscribe or procure subscribers for additional Shares up to a maximum of 15% of the total number of Shares comprised in the Global Offer (the "Overallotment Shares") at the Offer Price. The Overallotment Option will be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings of the Shares on the London Stock Exchange. Any Overallotment Shares issued pursuant to the Over-allotment Option will rank pari passu in all respects with the Shares, including for all dividends and other distributions declared, made or paid on the Shares, will be issued on the same terms and conditions as the Shares being issued or sold in the Global Offer and will form a single class for all purposes with the other Shares.

 

Duration:

This option may be exercised by the Stabilising Manager in whole or in one or more parts, on one or more occasions at any time from 30 April 2021 to 30 May 2021

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting, stabilising or maintaining the market price of the securities at a level higher than that which might otherwise prevail in the open market. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time without prior notice. Any stabilisation action or over-allotment shall be carried out in accordance with all applicable rules and regulations.

 

The Offer and the distribution of this announcement and other information in connection with the listing and Offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

 

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); (iii) any person to whom the communication may otherwise lawfully be made, and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons"). In the European Economic Area (the "EEA"), this announcement is addressed only to and directed only at, persons in member states who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation ((EU) 2017/1129) ("Qualified Investors"). This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STADKKBBABKKAQN
Date   Source Headline
26th Apr 20248:11 amRNSRecommended Cash Acquisition of Darktrace plc
23rd Apr 20242:09 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSQ3 FY 2024 Trading Update
9th Apr 20248:00 amRNSNew: The Darktrace ActiveAI Security Platform
3rd Apr 20241:32 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
25th Mar 202411:54 amRNSIssue & Allotment of Shares & Total Voting Rights
22nd Mar 20247:00 amRNSResult of Secondary Placing in Darktrace
21st Mar 20244:42 pmRNSProposed Secondary Placing in Darktrace
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20244:04 pmRNSDirector/PDMR Shareholding
13th Mar 202410:23 amRNSHolding(s) in Company
11th Mar 202410:42 amRNSHolding(s) in Company
7th Mar 20247:00 amRNSHalf-Year Results
5th Mar 20241:00 pmRNSDarktrace Federal: High "In Process" Designation
5th Mar 20247:00 amRNSDarktrace Appoints Chief People Officer
29th Feb 20244:53 pmRNSTotal Voting Rights
26th Feb 20243:31 pmRNSHolding(s) in Company
31st Jan 20244:45 pmRNSTotal Voting Rights
23rd Jan 20243:04 pmRNSHolding(s) in Company
15th Jan 20241:58 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNS1H FY 2024 Trading Update
3rd Jan 202411:39 amRNSIssue & Allotment of Shares & Total Voting Rights
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Dec 20234:06 pmRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20235:18 pmRNSDirector/PDMR Shareholding
7th Dec 20232:09 pmRNSResult of AGM
30th Nov 20234:41 pmRNSTotal Voting Rights
29th Nov 20234:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20239:13 amRNSAppointment of Independent Non-Executive Directors
20th Nov 20232:53 pmRNSHolding(s) in Company
7th Nov 20235:57 pmRNSNotice of AGM
7th Nov 20237:00 amRNSDarktrace Hosts Inaugural Technology Day
1st Nov 20237:00 amRNSEBT Market Purchase Programme
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20235:08 pmRNSTotal Voting Rights
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSDarktrace Unveils New Cloud Security Solution
26th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20231:45 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
17th Oct 202310:01 amRNSTransaction in Own Shares
16th Oct 20231:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.